Senti Biosciences Holdings: Pay

Senti Biosciences Holdings paid its 3 named executives $2.1M in total in FY2024 (Dec). CEO Timothy Lu, M.D., Ph.D. was paid $930.7K of that.

Pay$100 in the stock at the end of FY21 → $4
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Timothy Lu, M.D., Ph.D.Chief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years
Kanya Rajangam, M.D., Ph.D.President, Head of Research and Development and Chief Medical Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years
Yvonne LiInterim Chief Financial Officer
FY2024 (Dec)
1 year

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.